DRIPBaR Voluntarily Discontinues Health Claims for ALA IV Drips Following National Advertising Division Inquiry
New York, NY – March 20, 2025 – As part of its marketplace monitoring program, BBB National Programs’ National Advertising Division investigated claims made by The DRIPBaR in online and social media advertising regarding the benefits and efficacy of its Alpha Lipoic Acid (ALA) IV drip treatments.
The National Advertising Division (NAD) examined whether advertising for ALA drips conveyed the message that ALA drips can help, treat, or mitigate the progression of serious diseases, including cancer, Alzheimer’s, and chronic liver disease.
During the inquiry, DRIPBar informed NAD that it had permanently discontinued all the challenged claims. The voluntarily discontinued claims will be treated, for compliance purposes, as though NAD recommended they be discontinued.
In its advertiser statement, DRIPBaR stated it “thanks the NAD for the education it has provided and for its attention to this matter.”
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.
The National Advertising Division (NAD) examined whether advertising for ALA drips conveyed the message that ALA drips can help, treat, or mitigate the progression of serious diseases, including cancer, Alzheimer’s, and chronic liver disease.
During the inquiry, DRIPBar informed NAD that it had permanently discontinued all the challenged claims. The voluntarily discontinued claims will be treated, for compliance purposes, as though NAD recommended they be discontinued.
In its advertiser statement, DRIPBaR stated it “thanks the NAD for the education it has provided and for its attention to this matter.”
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.